These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 28544150)

  • 1. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized Controlled Trial Comparing a Human Acellular Dermal Matrix Versus Conventional Care for the Treatment of Venous Leg Ulcers.
    Cazzell S
    Wounds; 2019 Mar; 31(3):68-74. PubMed ID: 30720443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
    Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
    Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meta-analysis on the clinical effects of allogenic acellular dermal matrix treatment for diabetic foot ulcer].
    Xue CL; Hu ZC; Yang ZX; Li XJ
    Zhonghua Shao Shang Za Zhi; 2016 Dec; 32(12):725-729. PubMed ID: 28043296
    [No Abstract]   [Full Text] [Related]  

  • 5. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
    Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
    Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Reticular Acellular Dermal Matrix in the Healing of Chronic Diabetic Foot Ulcerations that Failed Standard Conservative Treatment: A Retrospective Crossover Study.
    Zelen CM; Orgill DP; Serena TE; Galiano RD; Carter MJ; DiDomenico LA; Kaufman JP; Keller J; Young NJ; Li WW
    Wounds; 2017 Feb; 29(2):39-45. PubMed ID: 28272011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
    Reyzelman AM; Bazarov I
    J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective, Multicenter, Single-Arm Clinical Trial for Treatment of Complex Diabetic Foot Ulcers with Deep Exposure Using Acellular Dermal Matrix.
    Cazzell S; Moyer PM; Samsell B; Dorsch K; McLean J; Moore MA
    Adv Skin Wound Care; 2019 Sep; 32(9):409-415. PubMed ID: 31361269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of acellular dermal matrix in diabetic foot ulcer treatment: A systematic review and meta-analysis.
    Guo X; Mu D; Gao F
    Int J Surg; 2017 Apr; 40():1-7. PubMed ID: 28232031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Composite Skin Grafting with Human Acellular Dermal Matrix Scaffold for Treatment of Diabetic Foot Ulcers: A Randomized Controlled Trial.
    Hu Z; Zhu J; Cao X; Chen C; Li S; Guo D; Zhang J; Liu P; Shi F; Tang B
    J Am Coll Surg; 2016 Jun; 222(6):1171-9. PubMed ID: 27068845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of PriMatrix, a fetal bovine acellular dermal matrix, in healing chronic diabetic foot ulcers: a prospective multicenter study.
    Kavros SJ; Dutra T; Gonzalez-Cruz R; Liden B; Marcus B; McGuire J; Nazario-Guirau L
    Adv Skin Wound Care; 2014 Aug; 27(8):356-62. PubMed ID: 25033310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a human acellular dermal wound matrix in patients with complex wounds and comorbidities.
    Williams ML; Holewinski JE
    J Wound Care; 2015 Jun; 24(6):261-2, 264-7. PubMed ID: 26075374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing Rates in a Multicenter Assessment of a Sterile, Room Temperature, Acellular Dermal Matrix Versus Conventional Care Wound Management and an Active Comparator in the Treatment of Full-Thickness Diabetic Foot Ulcers.
    Walters J; Cazzell S; Pham H; Vayser D; Reyzelman A
    Eplasty; 2016; 16():e10. PubMed ID: 26933467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
    Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
    J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Efficacy of Acellular Dermal Matrix Paste in Treating Diabetic Foot Ulcers.
    Lee M; Jun D; Choi H; Kim J; Shin D
    Wounds; 2020 Jan; 32(1):50-56. PubMed ID: 31876513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-derived Acellular Dermal Matrix Grafts for Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-analysis.
    Luthringer M; Mukherjee T; Arguello-Angarita M; Granick MS; Alvarez OM
    Wounds; 2020 Feb; 32(2):57-65. PubMed ID: 32155123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of negative-pressure wound therapy combined with porcine acellular dermal matrix for repairing deep burn wounds in limbs].
    Liu W; Li F; Chen X; Pan Q
    Zhonghua Shao Shang Za Zhi; 2016 Jun; 32(6):356-62. PubMed ID: 27321490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of fetal bovine acellular dermal matrix in severe diabetic foot ulceration and threatened limbs with tissue loss the use of FBADM as an adjunct for complex wounds.
    Gormley S; Hart O; French S; O'Shea C; Khashram M
    Vascular; 2024 Jun; 32(3):619-625. PubMed ID: 36415107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
    Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
    Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acellular Fish Skin Graft Use for Diabetic Lower Extremity Wound Healing: A Retrospective Study of 58 Ulcerations and a Literature Review.
    Michael S; Winters C; Khan M
    Wounds; 2019 Oct; 31(10):262-268. PubMed ID: 31730505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.